What Researchers Did
Researchers conducted a prospective randomized controlled study to evaluate the efficacy of topical hyperbaric oxygen therapy (THOT) in stimulating angiogenesis and healing necrotic or gangrenous wounds.
What They Found
The study found that 90% of wounds healed in the THOT group compared to only 22% in the standard wound care (SWC) control group. Ulcer size at 4 weeks was significantly smaller with THOT, and capillary density was significantly higher in THOT wounds compared to SWC wounds (P < 0.001).
What This Means for Canadian Patients
Topical hyperbaric oxygen therapy may offer a promising treatment option for Canadian patients suffering from necrotic or gangrenous wounds. This therapy could potentially accelerate wound healing and improve blood supply, leading to better outcomes for those with severe non-healing wounds.
Canadian Relevance
This study did not have a direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
The study's generalizability may be limited as it was conducted with inpatients and did not specify long-term outcomes beyond 4 weeks.